Akso Health Group(AHG)Earnings, Financials & Key Ratios
AHG•NASDAQ
$1.56
Price updated Jul 7, 2026
SectorFinancial ServicesIndustryCredit ServicesSub-IndustryConsumer Credit Issuers and Installment Lenders
AboutAkso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.Show more
- EBITDA-$164M
- Net Income-$135M-1327.0%
- EPS (Diluted)-0.48-23.1%
- Gross Margin-1.91%-137.7%
- EBITDA Margin-1110.82%
- Operating Margin-1125.37%-214.5%
- Net Margin-913.38%-133.1%
- ROE-79.97%-522.5%
AHG Price & Volume
Akso Health Group (AHG) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Losses Mask Significant Liquidity Reserves
Investment Thesis • Updated 2025Q4
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Mixed
Cash Flow:Burning
Primary Risk:Unsustainable operational cash burn
Key Thesis Takeaways
- Akso Health Group exhibits a precarious financial profile characterized by erratic revenue scaling and deep-seated operational inefficiencies, as evidenced by a 2025Q4 net loss of $67.2M.
- While the company maintains a substantial $176.2M cash position, this liquidity is largely derived from external capital injections rather than organic profitability, with retained earnings sitting at a negative $198.9M.
- Investors should remain cautious as the firm's aggressive acquisition strategy, which saw $18.8M in net outflows during 2025Q4, continues to outpace its ability to generate sustainable core earnings.
Verdict Logic
the company's fundamental inability to achieve positive operating margins, which reached -21.1% in 2025Q4, suggests that the current cash burn remains unsustainable despite the temporary $176.2M liquidity buffer.
AHG Growth Metrics
Akso Health Group (AHG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.27%
5 Years16.4%
3 Years35.05%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-1389.46%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM38.21%
Return on Capital
10 Years-18.69%
5 Years-66.08%
3 Years-81.58%
Last Year-97.95%
AHG Recent Earnings
Akso Health Group (AHG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat Revenue 0/12 qtrs (0%)
Q2 2025Latest
Mar 28, 2025Metric
Actual
Est
EPS
$0.00
—
Rev
$3M
—
Q3 2024
Jul 30, 2024Metric
Actual
Est
EPS
$0.04
—
Rev
$760,377
—
Q3 2024
Jul 12, 2024Metric
Actual
Est
EPS
$0.00
—
Rev
$3M
—
Q2 2024
Apr 30, 2024Metric
Actual
Est
EPS
$0.14
—
Rev
$760,377
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2025Latest | Mar 28, 2025 | $0.00 | $3M |
| Q3 2024 | Jul 30, 2024 | $0.04 | $760,377 |
| Q3 2024 | Jul 12, 2024 | $0.00 | $3M |
| Q2 2024 | Apr 30, 2024 | $0.14 | $760,377 |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Akso Health Group (AHG)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.56 | $525.99M | -3.25 | 512.08% | -913.38% | -79.97% | — | |
| $2.98 | $154.86M | 4.87 | -85.08% | 24.72% | 37.66% | — | |
| $14.51 | $1.89B | 1.15 | 8.83% | 33.86% | 24.95% | — | |
| $1.85 | $312.03M | 1.37 | -9.94% | 11.52% | 14.68% | — | |
| $4.71 | $1.17B | 3.42 | 1.03% | 18.75% | 6.05% | — | |
| $11.08 | $1.93B | 4.26 | -12.73% | 77.53% | 46.37% | — |
Compare AHG vs Peers
Akso Health Group (AHG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when AHG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AHG Frequently Asked Questions
Akso Health Group (AHG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Akso Health Group's revenue?
Akso Health Group (AHG) reported $14.8M in revenue for fiscal year 2025.
How fast is Akso Health Group growing?
Akso Health Group (AHG) grew revenue by 512.1% over the past year. This is strong growth.
Is AHG profitable?
Akso Health Group (AHG) reported a net loss of $135.0M for fiscal year 2025.
Dividend & Returns
What is AHG's return on equity?
Akso Health Group (AHG) has a return on equity (ROE) of -80.0%. Negative ROE indicates the company is unprofitable.
What is Akso Health Group's free cash flow?
Akso Health Group (AHG) generated $1.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.